Hourly refreshFri, Aug 7, 2026

Press Release Database

Recent press releases, indexed by topic.
AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
Results
Showing all · 55438 itemsDownloadExcelTXT
Finance · SaaS

Philips International Completes Acquisition of The Nash Group's Healthcare Businesses

Acquisition creates a healthcare services platform and advances Philips International's M&A program GREAT NECK, N.Y., Aug. 6, 2026 /PRNewswire/ -- Philips International today announced that it has completed the acquisition of the healthcare consulting, technology and recruiting businesses...

Aug 6 · 18:00mlpr-prnewswire-wire
SaaS · Education

TeenEbikeTraining.com Launches Canvas Integration and In-Person Teaching Toolkits for Schools

Leading E-Bike Safety Platform from the American Bicycling Education Association Expands Access with Seamless LMS Integration and Classroom Companion Presentation WINTER SPRINGS, Fla., Aug. 6, 2026 /PRNewswire-PRWeb/ -- TeenEbikeTraining.com, the nation's premier training curriculum for...

Aug 6 · 18:00PRWeb
AI

Why More Traders Are Exploring Chartless AI-Driven Trading with TruTrade

TruTrade's chartless AI-driven trading technology offers an alternative approach for traders seeking automation, flexibility, and a simplified trading experience. SCOTTSDALE, Ariz., Aug. 6, 2026 /PRNewswire/ -- TruTrade, a software company specializing in AI-driven trading technology, is...

Aug 6 · 17:59mlpr-prnewswire-wire
Finance

Lost Money on Erasca, Inc. (ERAS)? Join Class Action Before August ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 6, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ:ERAS) securities. If you suffered a loss on your Erasca, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Erasca, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Erasca, Inc. ..

Aug 6 · 17:57PR-Inside
In the wire

Antenna Testing for NASA’s SkyFall Mission

Description SkyFall ground-penetrating radar engineer Maya Román connects a coaxial cable to a test antenna in the Environmental Test Lab’s electromagnetic interference testing chamber at NASA’s Jet Propulsion Laboratory in Southern California. The antenna was pointed up during test to minimize reflections and interferences with the antenna pattern during the measurement. Equipped with four instruments each, the […]

Aug 6 · 17:56NASA
Finance

PNR INVESTOR DEADLINE: Pentair plc Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP urges Pentair plc (NYSE: PNR) investors who suffered substantial losses to submit their losses now. A securities fraud class action lawsuit has been filed against Pentair, and investors are encouraged to contact...

Aug 6 · 17:53PR Newswire
Finance

PHAR Investor Alert: Levi & Korsinsky Investigates Pharming Group N.V. ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 6, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Pharming Group N.V. ("Pharming Group N.V.") (NASDAQ:PHAR) concerning potential violations of the federal securities laws. Pharming Group stock dropped 22% on July 30, 2026, after the Company reported second-quarter revenue of $90.2 million -- down 3% year-over-year -- and cut its full-year 2026 revenue guidance to $375-$395 million from $405-$425 million. The revenue shortfall was primarily driven by RUCONEST, the Company's legacy hereditary angioedema therapy. RUCONEST sales fell 10% year-over-year to $72.3 million in the quarter. Joenja revenue ..

Aug 6 · 17:52PR-Inside
Finance

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now. A securities fraud class action lawsuit has been filed against Capricor, and investors are encouraged to...

Aug 6 · 17:52PR Newswire
In the wire

/C O R R E C T I O N -- Elong Power Holding Limited/

In the news release, Elong Power Holding Limited Announces the Change of Effective Date of its 1 for 45 Share Consolidations, issued 06-Aug-2026 by Elong Power Holding Limited over PR Newswire, we are advised by the company that the seventh paragraph, the pre-split number of shares...

Aug 6 · 17:50PR Newswire
Healthcare

OneLegacy Sets New Record for Organs Transplanted

LOS ANGELES, August 06, 2026--OneLegacy, the organ, eye, and tissue procurement organization serving seven counties in Southern California since 1977, set a new monthly record for July, enabling the transplantation of 210 lifesaving organs, thanks to the generosity of 71 donors and their families, and the expert coordination of dedicated medical teams.

Aug 6 · 17:49mlpr-businesswire
Finance

WIX INVESTOR ALERT: Wix.com Ltd. Investors with Substantial Losses Have Opportunity to Lead the Wix Class Action Lawsuit

SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Wix.com Ltd. (NASDAQ: WIX) that a securities class action has been filed in the wake of mid-May's massive 27% drop in the price of the company's shares after Wix announced its Q1 2026 financial...

Aug 6 · 17:49PR Newswire
Finance · Healthcare

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit

SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has been filed after its surprising revelations concerning a Phase 3 clinical trial of a therapy intended to...

Aug 6 · 17:48PR Newswire
← Prev1234620Next →